AMGN Amgen Inc revenue, earnings and financials
For the quarter ended June 30, 2026, Amgen Inc reported revenue of $10.1B (up 9.5% from a year earlier), net income of $2.38B and diluted EPS of $4.37; over the last four quarters revenue was $38.1B and net income $8.74B; for the fiscal year ended December 2025 revenue was $36.8B, up 10.0% on the year before.
AMGN annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $36.8B, gross profit n/a, operating income $9.08B, net income $7.71B (margin 21.0%), EPS $14.23
- Fiscal year ended Dec 2024: revenue $33.4B, gross profit n/a, operating income $7.26B, net income $4.09B (margin 12.2%), EPS $7.56
- Fiscal year ended Dec 2023: revenue $28.2B, gross profit n/a, operating income $7.90B, net income $6.72B (margin 23.8%), EPS $12.49
- Fiscal year ended Dec 2022: revenue $26.3B, gross profit n/a, operating income $9.57B, net income $6.55B (margin 24.9%), EPS $12.11
- Fiscal year ended Dec 2021: revenue $26.0B, gross profit n/a, operating income $7.64B, net income $5.89B (margin 22.7%), EPS $10.28
AMGN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $10.1B (up 9.5% year over year), net income $2.38B, EPS $4.37
- Quarter ended Mar 31, 2026: revenue $8.62B (up 5.8% year over year), net income $1.82B, EPS $3.34
- Quarter ended Dec 31, 2025 (from the annual report): revenue $9.87B (up 8.6% year over year), net income $1.33B, EPS $2.45
- Quarter ended Sep 30, 2025: revenue $9.56B (up 12.4% year over year), net income $3.22B, EPS $5.93
- Quarter ended Jun 30, 2025: revenue $9.18B (up 9.4% year over year), net income $1.43B, EPS $2.65
- Quarter ended Mar 31, 2025: revenue $8.15B (up 9.4% year over year), net income $1.73B, EPS $3.20
- Quarter ended Dec 31, 2024 (from the annual report): revenue $9.09B (up 10.9% year over year), net income $627M, EPS $1.17
- Quarter ended Sep 30, 2024: revenue $8.50B (up 23.2% year over year), net income $2.83B, EPS $5.22
- Quarter ended Jun 30, 2024: revenue $8.39B (up 20.1% year over year), net income $746M, EPS $1.38
- Quarter ended Mar 31, 2024: revenue $7.45B (up 22.0% year over year), net income −$113M, EPS −$0.21
- Quarter ended Dec 31, 2023 (from the annual report): revenue $8.20B (up 19.8% year over year), net income $767M, EPS $1.42
- Quarter ended Sep 30, 2023: revenue $6.90B (up 3.8% year over year), net income $1.73B, EPS $3.22
- Quarter ended Jun 30, 2023: revenue $6.99B (up 5.9% year over year), net income $1.38B, EPS $2.57
- Quarter ended Mar 31, 2023: revenue $6.11B (down 2.1% year over year), net income $2.84B, EPS $5.28
- Quarter ended Dec 31, 2022 (from the annual report): revenue $6.84B (down 0.1% year over year), net income $1.62B, EPS $3.00
- Quarter ended Sep 30, 2022: revenue $6.65B (down 0.8% year over year), net income $2.14B, EPS $3.98
- Quarter ended Jun 30, 2022: revenue $6.59B (up 1.0% year over year), net income $1.32B, EPS $2.45
- Quarter ended Mar 31, 2022: revenue $6.24B (up 5.7% year over year), net income $1.48B, EPS $2.68
- Quarter ended Dec 31, 2021 (from the annual report): revenue $6.85B, net income $1.90B, EPS $3.33
- Quarter ended Sep 30, 2021: revenue $6.71B, net income $1.88B, EPS $3.31
AMGN cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $9.96B, share buybacks $0, dividends $9.66 per share
- Fiscal year ended Dec 2024: operating cash flow $11.5B, share buybacks $200M, dividends $9.13 per share
- Fiscal year ended Dec 2023: operating cash flow $8.47B, share buybacks $0, dividends $8.64 per share
- Fiscal year ended Dec 2022: operating cash flow $9.72B, share buybacks $6.36B, dividends $7.95 per share
- Fiscal year ended Dec 2021: operating cash flow $9.26B, share buybacks $4.98B, dividends $7.22 per share
AMGN balance sheet
- Jun 30, 2026: cash $14.0B, total assets $95.6B, total liabilities n/a, shareholders' equity $11.7B, long-term debt $51.9B
- Mar 31, 2026: cash $12.0B, total assets $92.5B, total liabilities n/a, shareholders' equity $9.19B, long-term debt $51.9B
- Dec 31, 2025: cash $9.13B, total assets $90.6B, total liabilities n/a, shareholders' equity $8.66B, long-term debt $50.0B
- Sep 30, 2025: cash $9.45B, total assets $90.1B, total liabilities n/a, shareholders' equity $9.62B, long-term debt $52.4B
- Jun 30, 2025: cash $8.03B, total assets $87.9B, total liabilities n/a, shareholders' equity $7.43B, long-term debt $53.8B
- Mar 31, 2025: cash $8.81B, total assets $89.4B, total liabilities n/a, shareholders' equity $6.21B, long-term debt $54.0B
- Dec 31, 2024: cash $12.0B, total assets $91.8B, total liabilities n/a, shareholders' equity $5.88B, long-term debt $56.5B
- Sep 30, 2024: cash $9.01B, total assets $90.9B, total liabilities n/a, shareholders' equity $7.53B, long-term debt $56.9B
What is AMGN's revenue?
Amgen Inc reported $38.1B of revenue over its last four quarters, through June 30, 2026.
Is AMGN profitable?
Yes. Amgen Inc earned $8.74B over the last four quarters.
What is AMGN's EPS?
Diluted earnings per share over the last four quarters were $16.09; $4.37 in the latest quarter.
Does AMGN pay a dividend?
Amgen Inc paid $9.66 per share in dividends in the fiscal year ended December 2025.